Lung Nodule

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genomics
GenomicsUK - Oxford
1 program
Non-Invasive ctDNA Methylation Detection for Lung Nodule PatientsN/A1 trial
Active Trials
NCT03685669Unknown300Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GenomicsNon-Invasive ctDNA Methylation Detection for Lung Nodule Patients

Clinical Trials (1)

Total enrollment: 300 patients across 1 trials

NCT03685669GenomicsNon-Invasive ctDNA Methylation Detection for Lung Nodule Patients

Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients

Start: Jun 2017Est. completion: Dec 2019300 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space